Skip to main content
HLB SCIENCE Inc. logo

HLB SCIENCE Inc. — Investor Relations & Filings

Ticker · 343090 ISIN · KR7343090007 KO Professional, scientific and technical activities
Filings indexed 187 across all filing types
Latest filing 2022-05-24 Report Publication Anno…
Country KR South Korea
Listing KO 343090

About HLB SCIENCE Inc.

https://hlbscience.com/eng/index.php

HLB SCIENCE Inc. is a biopharmaceutical company specializing in the development of innovative drugs and diagnostics for infectious and immune-related diseases. The company's primary research focuses on creating therapeutics for sepsis, superbacteria infections, and Alzheimer's disease. Its key pipeline candidate for sepsis, DD-S052P, is a novel antibiotic designed to eliminate both bacteria and their associated endotoxins to mitigate cytokine storms. For Alzheimer's disease, HLB SCIENCE is advancing DD-A279, a treatment that modulates lipopolysaccharides (LPS) and gram-negative bacteria in the central nervous system. This therapeutic effort is complemented by the development of DD-A514, a diagnostic kit for the early detection of Alzheimer's.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location (online), and purpose of the meeting. It is not the presentation itself, but an announcement of the event, which falls under the category of general regulatory filings or announcements regarding company activities.
2022-05-24 Korean
주권매매거래정지해제(액면분할 주권 변경상장)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the lifting of a trading suspension for Dandi Bioscience due to a stock split. It does not fit into specific categories like financial reports or shareholder meetings, and it is a formal regulatory announcement issued by an exchange, making 'RNS' (Regulatory Filings) the most appropriate classification.
2022-04-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a specific executive (Park Yeong Min) at HLB Science Co., Ltd. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2022-04-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by company insiders (directors/executives) to disclose their shareholdings and changes therein. This corresponds to the 'Director's Dealing' category.
2022-04-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding for major shareholders (Park Yeong-min and special related parties) of HLB Science Co., Ltd. This document type is specifically used to notify the market when a shareholder's stake crosses certain thresholds or changes significantly, which corresponds to the 'Major Shareholding Notification' category.
2022-04-15 Korean
주권매매거래정지(주식의 병합, 분할 등 전자등록 변경, 말소)
Delisting Announcement Classification · 100% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for Dandi Bio Sciences due to a stock split. It is a regulatory announcement issued by an exchange or company regarding trading status, which does not fit into specific categories like earnings or dividends. Therefore, it falls under the fallback category for regulatory announcements.
2022-04-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.